Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induced preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver

Carcinogenesis

Volumn 17, Issue 11, 1996, Pages 2441-2448

  Tsuda, Hiroyuki ^a   Asamoto, Makoto ^a   Iwahori, Yoshio ^a   Hori, Takaaki ^a   Ota, Tomonori ^a   Baba Toriyama, Hiroyasu ^a   Uehara, Nobuaki ^a   Kim, Dae Joong ^a   Krutovskikh, Vladimir A ^a,d   Takasuka, Nobuo ^a   Tsuchiya, Takayuki ^b   Mutai, Mamoru ^b   Tatematsu, Masae ^c   Yamasaki, Hiroshi ^d  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; GAMMA GLUTAMYLTRANSFERASE; GAP JUNCTION PROTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE TRANSFERASE; LIVER ENZYME; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL MEMBRANE; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 10544245672     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.11.2441     Document Type: Article

References (59)

1. Hacker, H.J., Moore, M., Mayer, D. and Bannasch, P. (1982) Correlative histochemislry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in rat liver. Carcinoogenesis, 3, 1265-1272.
2. Ito, N., Tatematsu, M., Hasegawa, R. and Tsuda, H. (1989) Medium term bioassay system for detection of carcinogens and modifiers of hepatocarcinogens utilizing the GST-P positive liver cell focus as an end-point maker. Toxicol. Pathol., 17, 630-640.
3. Sato, K. (1989) Glutathione transferases as markers of preneoplasia. Adv. Cancer Res., 52, 205-255.
4. Tsuda, H., Moore, M.A., Asamoto, M., Inoue, T., Fukushima, S., Ito, N., Satoh, K., Amerizad, Z. and Oesch, F. (1987) Immunohistochemically demonstrated altered expression of cytochrome P-450 molecular forms and epoxide hydrolase in N-ethylhydroxyethylnitrosamine-induced rat kidney and liver lesions. Carcinogenesis, 8, 711-718.
5. Tsuda, H., Ozaki, K., Uwagawa, S., Yamaguchi, S., Hakoi, K., Aoki, T., Kato, T., Sato, K. and Ito, N. (1992) Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver cell lesions in rats. Jpn J. Cancer Res., 83, 1154-1165.
6. Yamaguchi, S., Hakoi, K., Ozaki, K., Kato, T., Danai, T., Nagao, S., Takahashi, H., Matsumoto, K. and Tsuda, H. (1993) Number of simultaneously expressed enzyme alterations correlates with progression of N-ethyl-N-hydroxyethylnitrosamine-induced hepatocarcinogenesis in rats. Jpn J. Cancer Res., 84, 1237-1244,.
7. Saez, J.C., Conner, J.A., Spray, D.C. and Bennett, M.V.L. (1989) Hepatocyte gap junctions are permeable to a second messenger, inositol 1,4,5-triphosphate and tocalcium ions. Proc. Natl Acad. Sci. USA, 86, 2708-2712.
8. Yamasaki, H. (1991) Aberrant expression and function of gap junctions during carcinogenesis. Environ. Health Perspect., 93, 191-197.
9. Klaunig, J.E. (1991) Alterations in intercellular communication during the stage of promotion. Proc. Soc. Exp. Biol. Med., 198, 688-692.
10. Fitzgerald, D.J., Mesnil, M., Oyamada, M., Tsuda, H., Ito, N. and Yamasaki, H. (1989) Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis. J. Cell Biochem., 41, 97-102.
11. Beer, D.C., Neveu, M.J., Paul, D.L., Rapp, U.R. and Pitot, H.C. (1986) Expression of the c-raf protooncogene: γ-glutamyltranspeptidase and gap junction protein in rat liver neoplasms. Cancer Res., 48, 1610-1617.
12. Janssen-Timmen, U., Traub, O., Dermietzel, R., Rabes, H.M. and Wilecke, K. (1986) Reduced number of gap junctions in rat hepatocarcinomas detected by monoclonal antibody. Carcinogenesis, 7, 1475-1482.
13. Tsuda, H., Asamoto, M., Baba, H. et al. (1995) Cell proliferation and advancement of hepatocarcinogenesis in the rat are associated with a decrease in connexin32 expression. Carcinogenesis, 16, 101-105.
14. Cattley, R.C., Miller, R.T. and Corton, J.C. (1995) Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development (Review). Prog. Clin. Biol. Res., 391, 295-303.
15. Hasegawa, R., Yoshida, T., Mizoguchi, Y., Futakuchi, M., Kim, D.J., Cui, L. and Ito, N. (1994) Phenotypic alteration of hepatocellular foci in rats treated with clofibrate and phenobarbital. Cancer Lett., 83, 89-95.
16. Popp, J.A., Cattley, R.C., Miller, R.T. and Marsman, D.S. (1994) Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis (Review). Prog. Clin. Biol. Res., 387, 193-207.
17. Rao, M.S. and Reddy, J.K. (1987) Peroxisome proliferation and hepatocarcinogenesis (Review). Carcinogenesis, 8, 631-636.
18. Yeldandi, A.V., Milano, M., Subbarao, V., Reddy, J.K. and Rao, M.S. (1989) Evaluation of liver cell proliferation during ciprolibrate-induced hepatocarcinogenesis. Cancer Lett., 47, 21-27.
19. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of the hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-58.
20. Meijer, A.E.F.H. and de Vries, G.P. (1974) Semipermeable membranes for improving the histochemical demonstration of enzyme activities in tissue sections. VI. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. Histochemistry, 40, 349-359.
21. Lojda, Z., Grossrau, R. and Schiebler, T.H. (1979) Enzyme Histochemistry, A Laboratory Manual. Springer Verlag, Berlin, Germany.
22. Sato, K., Kitahara, A., Satoh, K., Ishikawa, T., Tatematsu, M. and Ito, N. (1984) The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. Jpn J. Cancer Res., 75, 199-202.
23. Satoh, K., Kitahara, A., Soma, Y., Inaba, Y., Hayama, I. and Sato, K. (1985) Purification, induction and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical carcinogenesis. Proc. Natl Acad. Sci. USA, 82, 3964-3968.
24. Krutovskikh, V.A., Oyamada, M. and Yamasaki, H. (1991) Sequential changes of gap-junctional intercellular communications during multistage rat liver carcinogenesis: direct measurement of communication in vivo. Carcinogenesis, 12, 1701-1706.
25. Yamasaki, H., Krutovskikh, V., Mesnil, M., Columbano, A., Tsuda, H. and Ito, N. (1993) Gap junction intercellular communication and cell proliferation during rat liver carcinogenesis. Environ. Health Perspect., 101 (Suppl. 5), 191-198.
26. Harada, T., Maronpot, R.R., Morris, R.W. and Boorman, G.A. (1989) Observations on altered hepatocellular foci in National Toxicology Program two-year carcinogenicity studies in rats. Toxicol. Pathol., 17, 690-706.
27. Maronpot, R.R., Harada, T., Murthy, A.S. and Boorman, G.A. (1989) Documenting foci of hepatocellular alteration in two-year carcinogenicity studies: current practices of the National Toxicology Program (Review). Toxicol. Pathol., 17, 675-683.
28. Grasl-Kraupp, B., Waldhor, T., Huber, W. and Schulte-Hermann, R. (1993) Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis, 14, 2407-2412.
29. Chen, Z.Y., Liu, Y.E., He, C.Y., White, C.C. and Eaton, D.L. (1994) Inhibition of cell proliferation by ciprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules. Cancer Res., 54, 2622-2629.
30. Hosokawa, S., Tatematsu, M., Aoki, T., Nakanowatari, J., Igarashi, T. and Ito, N. (1989) Modulation of diethylnitrosamine-inhiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator. Carcinogenesis, 10, 2237-2241.
31. Greaves, P., Irisarri, E. and Monro, A.M. (1986) Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility. J Natl Cancer Inst., 76, 475-484.
32. Rao, M.S., Tatematsu, M., Subbarao, V., Ito, N. and Reddy, J.K. (1986) Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma-glutamyltranspeptidase. Cancer Res., 46, 5287-5290.
33. Rao, M.S., Usuda, N., Subbarao, V. and Reddy, J.K. (1987) Absence of γ-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethyyhexyl)phthalate, a peroxisome proliferator. Carcinogenesis, 8, 1347-1350.
34. Rao, M.S., Nemali, M.R., Usuda, N., Scarpelli, D.G., Makino, T., Pitot, H.C. and Reddy, J.K. (1988) Lack of expression of glutathione-S-transferasc P, γ-glutamyl transpeptidase, and α-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Cancer Res., 48, 4919-4925.
35. Mutai, M., Tatematsu, M., Aoki, T., Wada, S. and Ito, N. (1990) Modulatory interaction between initial clofibrate treatment and subsequent administration of 2-acetylaminofluorene or sodium phenobarbital on glutathione S-transferase positive lesion development. Cancer Lett., 49, 127-132.
36. Gerbracht, U., Bursch, W., Kraus, P., Putz, B., Reinacher, M., Timmermann, T.I. and Schulte-Hermann, R. (1990) Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver. Carcinogenesis, 11, 617-624.
37. Cattley, R.C. and Popp, J.A. (1989) Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res., 49, 3246-3251.
38. Plenat, F., Braun, L. and Fausto, N. (1988) Demonstration of glucose-6-phosphatase and peroxisomal catalase activity by ultrastructural cytochemistry in oval cells from livers of carcinogen-treated rats. Am. J. Pathol., 130, 91-102.
39. Marsman, D.S. and Popp, J.A. (1994) Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14643. Carcinogenesis, 15, 111-117.
40. Weber, E., Moore, M.A. and Bannasch, P. (1988) Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiadrosterone and N-nitrosomorpholine. Carcinogenesis, 9, 1049-1054.
41. Rasheed, B.K., Chhabra, S. and Kurup, C.K. (1980) Influence of starvation and clolibrate administration on oxidative phosphorylation by rat liver mitochondria. Biochem. J., 190, 191-198.
42. Fitzgerald, D.J., Swierenga, S.H., Mesnil, M., Piccoli, C., Marceau, N. and Yamasaki, H. (1993) Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis (Review). Environ. Health Perspect., 5, 191-197.
43. Krutovskikh, V.A., Mesnil, M., Mazzoleni, G. and Yamasaki, H. (1995) Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Association with aberrant localization of connexin proteins. Lab. Invest., 72, 571-577.
44. Hully, J.R. et al. (1994) Transgenic hepatocarcinogenesis in the rat. Am. J. Pathol., 145, 386-397.
45. Conway, J.G., Cattley, R.C., Popp, J.A. and Butterworth, B.E. (1989) Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res., 49, 3246-3251.
46. Cattley, R.C., Marsman, D.S. and Popp, J.A. (1991) Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver. Carcinogenesis, 12, 469-473.
47. Cattley, R.C. and Glover, S.E. (1993) Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization. Carcinogenesis, 14, 2495-2499.
48. Kasai, H., Okada, Y., Nishimura, S., Rao, M.S. and Reddy, J.K. (1989) Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res., 49, 2603-2605.
49. Hegi, M.E., Fox, T.R., Belinsky, S.A., Devereux, T.R. and Anderson, M.W. (1993) Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprolibrate, a potent peroxisome proliferator. Carcinogenesis, 14, 145-149.
50. Olson, M.J. (1988) DNA strand breaks induced by hydrogen peroxide in isolated rat hepatocytes. J. Toxicol. Environ. Health, 23, 407-423.
51. Ward, J.M., Diwan, B.A., Oshima, M., Hu, H., Shuller, H.M. and Rice, J.M. (1986) Tumor-initiating and promoting activities of di(2-ethylhexyl)-phthalate in vivo and in vitro. Environ. Health Perspect., 65, 279-291.
52. Kraupp, G.B., Huber, W., Taper, H. and Schulte, H.R. (1991) Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res., 51, 666-671.
53. Cattley, R.C., Kato, M., Popp, J.A., Teets, V.J. and Voss, K.S. (1994) Initiator-specific promotion of hepatocarcinogenesis by WY-14,643 and clofibrate. Carcinogenesis, 15, 1763-1766.
54. Klaunig, J.E., Ruch, R.J., Hampton, J.A., Weghorst, C.M. and Hartnett, J.A. (1990) Gap-junctional intercellular communication and murine hepatic carcinogenesis. Prog. Clin. Biol. Res., 331, 277-291.
55. Neveu, M.J., Hully, J.R., Paul, D.L. and Pitot, H.C. (1990) Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation. Cancer Commun., 2, 21-31.
56. Sakamoto, H., Oyamada, M., Enomoto, K. and Mori, M. (1992) Differential changes in expression of gap junction proteins connexin 26 and 32 during hepatocarcinogenesis in rats. Jpn J. Cancer Res., 83, 1210-1215.
57. Oyamada, M., Krutovskikh, V.A., Mesnil, M., Partensky, C. Berger, F. and Yamasaki, H. (1990) Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: increased expression of cardiac-type gap junction gene connexin 43. Mol. Carcinogenesis, 3, 273-278.
58. Neveu, M.J., Hully, J.R., Babcock, K.L., Hertzberg, E.L., Nicholson, B.J., Paul, D.L. and Pitot, H.C. (1994) Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver. J Cell Sci., 107, 83-95.
59. Morimura, S., Suzuki, T., Hochi, S., Yuki, A., Nomura, K., Kitagawa, T., Nagatsu, I., Imagawa, M. and Muramatsu, M. (1993) Trans-activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat. Proc. Natl Acad. Sci. USA, 90, 2065-2068.